 |
 |
 |
 |
|
|
|
|
|
|
| |
Department of Pediatrics, Nihon University Hospital
|
| |
1-6 Kandasurugadai, Chiyoda-ku, Tokyo 101-8309, Japan
|
| |
TEL:81-3-3293-1711
|
| |
FAX:81-3-3293-2880
|
|
|
|
|
| |
c/o GRESS CORPORATRION
|
| |
DAINI-TAKAYAMA-Building, 1-16-4, Shibadaimon, Minato-ku, Tokyo 105-0012
|
| |
TEL : 81-3-6435-9885
|
| |
FAX : 81-3-6435-9886
|
| |
E-mail:jspe52@gressco.jp
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| In the 52nd JSPE Annual Meeting, we will have some English Sessions, which will be presented in English.
And within that sessions, we will have a session for presenters from Asian countries,
entitled `Asia Session`.
|
|
|
| ■SUBMISSION DEADLINE
|
|
|
| |
May 16(Wed.) 2018 at noon June 15(Fri.) 2018 at noon |
|
|
| ■GUIDELINE for SUBMISSION
|
|
|
| |
1. |
Presentation style
Will be Oral presentation, but determined by chairperson, finally. |
| |
2. |
Disclosure of Potential Conflicts of Interest
When submitting an abstract, the presenting author and all the co-presenters are required to check whether there are conflicts of interest with a company or for-profit group related to the subject of the presentation. You should disclose the status of the COI for the past three years, by two ways, below.
|
| |
|
1) |
Must write down at the end of the abstract, whether author(s) have any COI relationship to disclose, or don’t have.
Ex) I have COI relationship should be disclosed. / I don`t have COI relationship should be disclosed.
|
| |
|
2) |
Must disclose your status of the COI during your presentation at the annual meeting.
|
| |
Please refer to the following detailed regulations for more information: |
| |
Detailed Regulations of COI (Conform to the regulations of the Japan Pediatric Society) |
| |
|
① |
If you have been an officer or consultant in a business, corporation or for-profit organization, or commercial entity involved in clinical research (hereinafter, “business, organization or group”), if the remuneration from a single business, organization or group exceeds 1 million yen per year.
|
| |
|
② |
Concerning stock ownership or options, if the profit (total sum of the dividend or profit sales) from stocks of one business, organization or group totals more than 1 million yen per year, or if 5% or more of all stocks of the corresponding stock is owned.
|
| |
|
③ |
Patent right fees, from a business, organization or group, of 1 million yen or more per patent fee, per year.
|
| |
|
④ |
Remuneration for attending meetings (presentations) from businesses, organizations or groups, paid for the time and effort of the daily activity (lectures etc.) which is 500,000 yen or more from 1 organization or group per year.
|
| |
|
⑤ |
Regarding manuscript fees paid for writing of pamphlets etc. by businesses, organizations or groups, 500,000 yen or more per business, organization or group, per year.
|
| |
|
⑥ |
Regarding research funds for medical studies (trust research funds, joint research funds) provided by businesses, organizations or groups, an annual total of 1 million yen or more for 1 organization or group, to the individual disclosing COI or to the affiliated department of the individual disclosing COI (department, field) or to the department in which the individual disclosing COI is director.
|
| |
|
⑦ |
For scholarship funds granted by businesses, organizations or groups, an annual total of 1 million yen or more from 1 organization or group, to the individual disclosing COI or to the affiliated department of the individual disclosing COI (department, field) or to the department in which the individual disclosing COI is director.
|
| |
|
⑧ |
If the individual disclosing COI is affiliated with the endowed department sponsored by the businesses, organizations or groups.
|
| |
|
⑨ |
Concerning other travel expenses, gifts, or contributions unrelated to the research, an annual total of 50,000 yen or more by 1 business, organization or group.
|
| |
|
⑩ |
If receiving service provision by businesses, organizations or groups, without making a contract, such as joint research.
|
| |
|
⑪ |
If author`s relatives who is within the first degree of relationship, is working at businesses, organizations or groups that falling under any of the above ① to ⑩.
|
| |
3. |
Submission
We accept abstract submission via e-mail attachment only.Please click the button below and download the Abstract Submission Form (MS Word).After completing the form, please send it to the meeting secretariat via e-mail (jspe52@gressco.jp).
Please write e-mail subject as 'abstract submission plus your name'.
EX) abstract submission John Smith
|
| |
|
( MS Word )
|
| |
4. |
Format
(1) Language
· English
(2) Volume(title)
· Must be 100 characters or less in single-byte, including spaces and punctuations.
(3) Volume (abstract body, authors and institutions not included)
· Must be 1,600 characters or less in single-byte, including spaces and punctuations.
· It can include one diagram, which should be in GIF or JPEG format and 4MB or less in size.
However, if the abstract includes a diagram, the body of the abstract must be 1,072 characters or less, in single-byte, including spaces and punctuations.
(4) Institution of the Author
· Should write abbreviations like that ‘Dept. of Pediatr., ◯◯ Univ. Sch. of Med./ ◯◯ Hosp.’
(5) Note
· The abstract should clearly and specifically describe the intent of the presentation in the order of introduction, purpose, case, methods, results, conclusion and discussion.
(6) Categories
· Abstract should be submitted under the following categories:
|
| |
|
<Categories 1>
Choose A or B
A.Basic
B.Clinical
|
| |
|
<Categories 2>
Choose one or two from the following options.
A.Diabetes, Lipid Disorders
B.Adrenal Disorders
C.Sexual Development Disorders
D.Thyroid Disorders
E.Disorders of Calcium and Mineral Metabolism
F.Pituitary, Growth Disorders
|
| |
5. |
Responsibility of correctness/ Modify
·Any corrections to be made to your abstract will be your own responsibility.
·You can’t modify your abstract after the submission deadline. |
| |
6. |
Notification of submission
· Notification of submission acceptance will be sent by e-mail. If you do not receive an acceptance notification e-mail within a week, after the submission, please contact to the secretariat (jspe52@gressco.jp).
|
| |
7. |
Review
· Submitted abstracts will be reviewed by the Organize Committee, and the acceptance or rejection of the submitted abstract will be announced to the applicants via e-mail by the end of July 2018. |
|
|
| ■INQUIRY
|
|
|
| |
Meeting Secretariat:
c/o GRESS CORPORATRION
Email:jspe52@gressco.jp |
|
|
|
|
|
|
|
